Fig. 5: Comparison of mIF samples from residual cancer patients (Non pCR) and those who eventually attained a pathology complete response (pCR). | npj Breast Cancer

Fig. 5: Comparison of mIF samples from residual cancer patients (Non pCR) and those who eventually attained a pathology complete response (pCR).

From: A pilot study incorporating HER2-directed dendritic cells into neoadjuvant therapy of early stage HER2+ER- breast cancer

Fig. 5

There was a trend for pCR patients to have greater elevations in CD3 + IFNγ+ cells within their stroma after 4 weeks of DC1 vaccination compared to Non pCR patients while NKT cells appeared similar between the two groups. T cell and NKT infiltration was increased in both groups relative to baseline.

Back to article page